glp 1 agonist medullary thyroid cancer GLP-1 Receptor Agonists: A Promising Therapy for Modern Lifestyle Diseases with Unforeseen Challenges Exploring the Side Effects of
Description
It is fat loss with function preserved
2021;22(22) doi: 10.3390/ijms222212165

One important change is that they state, GLP-1 RA therapy may be continued preoperatively in patients without elevated risk of delayed gastric emptying. The risk factors they state include: escalation phase of dosing, higher dose, weekly dosing (as opposed to daily dosing), gastrointestinal symptoms (nausea, vomiting, abdominal pain, dyspepsia, constipation), and medical conditions that may cause delayed gastric emptying

Cardiovasc Diabetol (2022) 21(1):42

El Ansari W, Elhag W

Cost-effectiveness analyses using real-world data: an overview of the literature
